Pericarditis News and Research

RSS

Pericarditis is defined as the state of inflammation or infection of the pericardium, the membranous sac that encloses the heart. The cause and severity of pericarditis determines the type of treatment appropriate for this condition.

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Researchers modeled the benefit-risk of Moderna’s COVID-19 mRNA-1273 vaccine.

12 Dec 2022

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Can monkeypox infection lead to myocarditis?

A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.

13 Nov 2022

The comparative risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273 second doses

Researchers assessed the risk of myocarditis or pericarditis after the COVID-19 mRNA vaccine second doses.

10 Nov 2022

Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines

Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in the Journal of the American College of Cardiology.

7 Nov 2022

Did active monitoring detect potentially elevated risk of health outcomes following BNT162b2 COVID-19 vaccination in the US pediatric population aged 5-17 years?

Researchers used a nearly real-time monitoring framework for early detection of potential safety signals following the administration of the BNT162b2 vaccine in over three million United States children aged five to 17 years.

2 Nov 2022

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination.

1 Nov 2022

In mild cases of COVID, blood clot risk is higher

Researchers examine the association between COVID-19 and increased cardiovascular outcomes and mortality sequelae.

27 Oct 2022

Avian influenza virus introduced from Europe to North America through Iceland

A new study indicated that Iceland was the stepping stone for the translocation of the highly pathogenic avian influenza virus (HPAIV) between North America and Europe.

25 Oct 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Scientists determine the risk of myocarditis and pericarditis among young individuals who have received mRNA-based COVID-19 vaccines.

19 Oct 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

Pericarditis News and Research

Further Reading

The benefit-risk of the mRNA-1273 COVID-19 vaccine

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

Can monkeypox infection lead to myocarditis?

The comparative risk of myocarditis, pericarditis, and myopericarditis between BNT162b2 and mRNA-1273 second doses

Researchers compare the risk of myocarditis between Pfizer and Moderna COVID-19 vaccines

Did active monitoring detect potentially elevated risk of health outcomes following BNT162b2 COVID-19 vaccination in the US pediatric population aged 5-17 years?

New analysis on the risk for myocarditis or pericarditis after mRNA COVID-19 vaccination

In mild cases of COVID, blood clot risk is higher

Avian influenza virus introduced from Europe to North America through Iceland

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

Study shows low risk of myocarditis/pericarditis after mRNA COVID-19 vaccination

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

Persistent cardiac symptoms in individuals with mild initial COVID-19

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

Severe COVID-19 increases risk of future cardiovascular events

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Beyond COVID-19: the potential future applications of mRNA vaccines

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News